Medical Cannabis Cultivation - Companies Growing in Europe

When exploring the best European cannabis companies, don't forget to notice that many of them focus on medical advancement and research. Although a large part of Europe still does not allow recreational cannabis use, many companies continue to explore the benefits of this plant. The cannabis industry is growing in both the US and Europe, making it a very attractive market.

Sanity Group

The company Sanity Group/Vayamed originated in Germany and has since expanded to provide services in the broader European market. The European market generally does not offer recreational cannabis use, which means that a larger part of the market focuses on other uses, such as medical, scientific, and personal care. The company is involved in research and development projects and also non-psychoactive CBD products. Sanity Group seeks to develop broader health benefits associated with cannabis by carefully balancing tasks between several expert teams, such as a medical advisory team, political advisory board, and investors. The company believes that cannabis research has the potential to improve overall individual health while ultimately improving access to these products for people in Europe. One of the main components of Sanity Group's success stems from its ability to utilize and recognize the needs of different markets across Europe in terms of different regulations and varying healthcare expectations.

Curaleaf International

Curaleaf International operates in 10 different countries and owns more than 15 medical cannabis licenses. The company focuses on a seed-to-patient approach, where cannabis is overseen by Curaleaf International's vertically integrated supply chain. Vertical integration allows Curaleaf International to oversee steps that are typically performed by other companies. This approach enables Curaleaf International greater control and improves the ability to maintain higher standards. One way Curaleaf International maintains control over individual steps is by controlling multiple companies. For example, the company owns a medical cannabis cultivation facility, a research and development company, a manufacturing company, and a medical cannabis pharmacy.

The two main areas where research and excellence converge are healthcare and patient services. In medical research, the company seeks to present information in peer-reviewed journals and conferences to partially support its visibility. Their business model supports the company's vision: to make high-quality cannabis accessible to those who need it.

[Translation continues in the same manner for the remaining sections...]